150 related articles for article (PubMed ID: 33811994)
21. Cryptococcus neoformans/Cryptococcus gattii species complex melanized by epinephrine: Increased yeast survival after amphotericin B exposure.
Brilhante RSN; Rocha MGD; Oliveira JS; Pereira-Neto WA; Guedes GMM; Cordeiro RA; Sidrim JJC; Rocha MFG; Castelo-Branco DSCM
Microb Pathog; 2020 Jun; 143():104123. PubMed ID: 32169493
[TBL] [Abstract][Full Text] [Related]
22. Syntheses of antifungal aureobasidin A analogs with alkyl chains for structure-activity relationship.
Kurome T; Inoue T; Takesako K; Kato I
J Antibiot (Tokyo); 1998 Mar; 51(3):359-67. PubMed ID: 9589073
[TBL] [Abstract][Full Text] [Related]
23. The Antimicrobial Peptide MK58911-NH
Singulani JL; Oliveira LT; Ramos MD; Fregonezi NF; Gomes PC; Galeane MC; Palma MS; Fusco Almeida AM; Mendes Giannini MJS
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0090421. PubMed ID: 34516241
[TBL] [Abstract][Full Text] [Related]
24. Anti-microbial and anti-biofilm activities of combined chelerythrine-sanguinarine and mode of action against Candida albicans and Cryptococcus neoformans in vitro.
Qian W; Yang M; Li X; Sun Z; Li Y; Wang X; Wang T
Colloids Surf B Biointerfaces; 2020 Jul; 191():111003. PubMed ID: 32276211
[TBL] [Abstract][Full Text] [Related]
25. IPC synthase as a useful target for antifungal drugs.
Sugimoto Y; Sakoh H; Yamada K
Curr Drug Targets Infect Disord; 2004 Dec; 4(4):311-22. PubMed ID: 15578972
[TBL] [Abstract][Full Text] [Related]
26. Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.
Selb R; Fuchs V; Graf B; Hamprecht A; Hogardt M; Sedlacek L; Schwarz R; Idelevich EA; Becker SL; Held J; Küpper-Tetzel CP; McCormick-Smith I; Heckmann D; Gerkrath J; Han CO; Wilmes D; Rickerts V
Int J Med Microbiol; 2019 Sep; 309(6):151336. PubMed ID: 31444102
[TBL] [Abstract][Full Text] [Related]
27. Fungicidal mechanism of action of D0870 against Cryptococcus neoformans under acidic conditions.
Yamada H; Watanabe T; Kato K; Mochizuki H
Antimicrob Agents Chemother; 1997 Dec; 41(12):2710-3. PubMed ID: 9420043
[TBL] [Abstract][Full Text] [Related]
28. New Triazole NT-a9 Has Potent Antifungal Efficacy against Cryptococcus neoformans
Lu RY; Ni TJ; Wu J; Yan L; Lv QZ; Li LP; Zhang DZ; Jiang YY
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31791946
[TBL] [Abstract][Full Text] [Related]
29. Bestowing antifungal and antibacterial activities by lipophilic acid conjugation to D,L-amino acid-containing antimicrobial peptides: a plausible mode of action.
Avrahami D; Shai Y
Biochemistry; 2003 Dec; 42(50):14946-56. PubMed ID: 14674771
[TBL] [Abstract][Full Text] [Related]
30. Investigation of Antifungal Mechanisms of Thymol in the Human Fungal Pathogen,
Jung KW; Chung MS; Bai HW; Chung BY; Lee S
Molecules; 2021 Jun; 26(11):. PubMed ID: 34200464
[TBL] [Abstract][Full Text] [Related]
31. Endophytic fungal compounds active against Cryptococcus neoformans and C. gattii.
Pereira CB; de Oliveira DM; Hughes AF; Kohlhoff M; LA Vieira M; Martins Vaz AB; Ferreira MC; Carvalho CR; Rosa LH; Rosa CA; Alves TM; Zani CL; Johann S; Cota BB
J Antibiot (Tokyo); 2015 Jul; 68(7):436-44. PubMed ID: 25712396
[TBL] [Abstract][Full Text] [Related]
32. Discovery of biphenyl imidazole derivatives as potent antifungal agents: Design, synthesis, and structure-activity relationship studies.
Zhao D; Zhao S; Zhao L; Zhang X; Wei P; Liu C; Hao C; Sun B; Su X; Cheng M
Bioorg Med Chem; 2017 Jan; 25(2):750-758. PubMed ID: 27955926
[TBL] [Abstract][Full Text] [Related]
33. Antifungal and Antibiofilm In Vitro Activities of Ursolic Acid on Cryptococcus neoformans.
Wang WJ; Liu CC; Li YT; Li MQ; Fu YT; Li XC; Jie-Kang ; Qian WD
Curr Microbiol; 2022 Aug; 79(10):293. PubMed ID: 35972650
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, Characterization and Antifungal Evaluation of Novel Thiochromanone Derivatives Containing Indole Skeleton.
Han XY; Zhong YF; Li SB; Liang GC; Zhou G; Wang XK; Chen BH; Song YL
Chem Pharm Bull (Tokyo); 2016 Sep; 64(9):1411-6. PubMed ID: 27373770
[TBL] [Abstract][Full Text] [Related]
35. Effects of microplusin, a copper-chelating antimicrobial peptide, against Cryptococcus neoformans.
Silva FD; Rossi DC; Martinez LR; Frases S; Fonseca FL; Campos CB; Rodrigues ML; Nosanchuk JD; Daffre S
FEMS Microbiol Lett; 2011 Nov; 324(1):64-72. PubMed ID: 22092765
[TBL] [Abstract][Full Text] [Related]
36. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
Nishikawa MM; Almeida-Paes R; Brito-Santos F; Nascimento CR; Fialho MM; Trilles L; Morales BP; da Silva SA; Santos W; Santos LO; Fortes ST; Cardarelli-Leite P; Lázera MDS
Med Mycol; 2019 Oct; 57(7):864-873. PubMed ID: 30657975
[TBL] [Abstract][Full Text] [Related]
37. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
Hagen F; Hare Jensen R; Meis JF; Arendrup MC
Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
[TBL] [Abstract][Full Text] [Related]
38. Blap-6, a Novel Antifungal Peptide from the Chinese Medicinal Beetle
Zhang LM; Zhou SW; Huang XS; Chen YF; Mwangi J; Fang YQ; Du T; Zhao M; Shi L; Lu QM
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791374
[No Abstract] [Full Text] [Related]
39. Novel imidazo[2,1-b]-1,3,4-thiadiazoles as promising antifungal agents against clinical isolate of Cryptococcus neoformans.
Alwan WS; Karpoormath R; Palkar MB; Patel HM; Rane RA; Shaikh MS; Kajee A; Mlisana KP
Eur J Med Chem; 2015 May; 95():514-25. PubMed ID: 25847769
[TBL] [Abstract][Full Text] [Related]
40. Activity of VT-1129 against Cryptococcus neoformans clinical isolates with high fluconazole MICs.
Nielsen K; Vedula P; Smith KD; Meya DB; Garvey EP; Hoekstra WJ; Schotzinger RJ; Boulware DR
Med Mycol; 2017 Jun; 55(4):453-456. PubMed ID: 27664991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
